The Cure Sickle Cell Initiative Economic Analysis: An Evaluation of the Costs of Sickle Cell Disease and Potential Health Plan Budget Impacts of Gene Therapy as a New Treatment Option
$336,866OT3FY2019HLNIH
Fred Hutchinson Cancer Research Center, Seattle WA
Investigators
Linked publications, trials & patents
Paper 38252942Paper 36929166Paper 36773220Paper 36445914Paper 35715626Paper 35575558Paper 35482721Paper 35471578Paper 35094801Paper 34368937
Abstract
No abstract provided
View original record on NIH RePORTER →